American Health & Drug Benefits

Recent Articles

Editorial

A Sylvatic or Syncretic Approach to Healthcare Innovation?

David B. Nash, MD, MBA

Business, Review Article

Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward

Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD

Clinical, Review Article

The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes

David L. Larsen, RN, MHA; Hitesh Gandhi, MBBS; Michael Pollack, MS; Norbert Feigler, MD; Sushma Patel, PharmD; Robert A. Wise, MD

A Sylvatic or Syncretic Approach to Healthcare Innovation?

David B. Nash, MD, MBA

A Hollywood-Style Teachable Moment

David B. Nash, MD, MBA

A Pandemic Literary Genre

David B. Nash, MD, MBA

Most Popular Articles

Business, Review Article

Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward

Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD

Clinical, Review Article

The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes

David L. Larsen, RN, MHA; Hitesh Gandhi, MBBS; Michael Pollack, MS; Norbert Feigler, MD; Sushma Patel, PharmD; Robert A. Wise, MD

Editorial

A Sylvatic or Syncretic Approach to Healthcare Innovation?

David B. Nash, MD, MBA

Clinical, Review Article

Mental Illness Disclosure in the Workplace: An Opportunity for Improvement

Gary Branning, MBA; Heidi C. Waters, PhD; Christy R. Houle, PhD, MPH; Stacey L. Worthy, Esq; Betsy Fink, MBA, PMP; Katie Hayes

Editorial

A Hollywood-Style Teachable Moment

David B. Nash, MD, MBA

Editorial

A Pandemic Literary Genre

David B. Nash, MD, MBA

Web Exclusives

Oncology Overview

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45

FDA Approvals

Yescarta First CAR T-Cell Therapy FDA Approved for Large B-Cell Lymphoma

FDA Approvals

Tibsovo Received a New Indication, in Combination with Azacitidine, for Newly Diagnosed Patients with AML and IDH1 Mutation

View the Latest Issue

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.